Form 4: ParkerVision Director Acquires 370K Stock Options

ParkerVision Director Robert Greene Sterne was granted 370,000 stock options as compensation for his 2026 Board service.

Summary

• Robert Greene Sterne, a Director of ParkerVision Inc. (PRKR), acquired 370,000 derivative securities in the form of options to purchase common stock.
• The transaction date for this acquisition was January 22, 2026.
• Each option has an exercise price of $0.24.
• The options were awarded as compensation for Mr. Sterne's 2026 Board service.
• The options will vest in two equal bi-annual increments, with the first vesting on July 22, 2026, and the second on January 22, 2027.
• The options have an expiration date of January 22, 2031.
• Following this transaction, Mr. Sterne beneficially owns 370,000 derivative securities directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it represents a routine compensation event, it positively aligns the director's interests with shareholders and is a standard corporate governance practice. It does not indicate any immediate operational or financial changes.

Positives

• The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term performance.
• Equity compensation is a common practice that helps attract and retain qualified board members.

Negatives

• The exercise of these options in the future could lead to a degree of share dilution for existing shareholders.

Risks

• The value of the options is tied to the future market price of ParkerVision's common stock, meaning they may not be exercised if the stock price does not exceed the exercise price.
• Potential future dilution if all options are exercised.

Future Outlook

The option grant for 2026 Board service indicates the continued engagement of Robert Greene Sterne as a Director for ParkerVision Inc. through at least 2026, with vesting extending into 2027.

Industry Context

The granting of stock options to directors is a standard and widely accepted practice in corporate governance across various industries. It serves as a form of non-cash compensation and a mechanism to align the interests of board members with those of the company's shareholders.

Comparison to Industry Standards

• Equity compensation for directors, such as stock options, is a common practice among publicly traded companies, including those in the technology and intellectual property sectors like ParkerVision. This aligns with global benchmarks for executive and board remuneration.
• The vesting schedule, typically over several years, is also standard, designed to encourage long-term commitment and performance.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also benefit from increased alignment of director's interests with long-term company performance.
• Director (Robert Greene Sterne): Receives equity compensation for board service, providing a direct financial incentive tied to the company's stock performance.

Next Steps

• The options will vest in two equal bi-annual increments on July 22, 2026, and January 22, 2027.

Key Dates

Recommendation

This Form 4 reports a standard equity compensation grant to a director, which is a routine corporate governance event and does not provide new information that would significantly alter the investment thesis for ParkerVision Inc. It aligns the director's interests with shareholders but does not indicate a material change in company performance or outlook, thus warranting a 'hold' recommendation.

Keywords

ParkerVision, PRKR, stock options, director compensation, Form 4, insider transaction, equity grant, Robert Greene Sterne, corporate governance